Group 1 - The "Xinjiang Drug Research and Innovation and Industry Exchange Seminar" was held in Urumqi, focusing on the development direction of Xinjiang's pharmaceutical innovation, with participation from various sectors including government, finance, education, technology, and medicine [1] - Xinjiang's unique traditional Chinese medicine resources are being leveraged through government support and state-owned enterprises to promote industry upgrades and establish competitive regional brands [1] - The establishment of the academician workstation led by Academician Yang Baofeng provides high-end intellectual support for drug research and development in Xinjiang [1] Group 2 - A strategic cooperation framework agreement was signed between Xinjiang Medical University and Xinjiang Financial Investment Group, focusing on talent cultivation, scientific research innovation, and market development [2] - Keynote speeches were delivered on topics such as multidisciplinary innovation in drug development and the discovery of novel drug sources from Central Asian medicinal materials [2] - Dezheng Health, a leading domestic lipid-lowering drug company, has established a comprehensive R&D system and is actively advancing multiple innovative drug projects [2] Group 3 - Dezheng Health signed a cooperation framework agreement with Academician Yang Baofeng to collaborate on drug research and development across various disease areas [3] - The newly established academician workstation will focus on small molecule drugs, peptide drugs, and non-toxic active ingredients from industrial hemp, promoting drug development and industrialization [3] - The establishment of a "Technology Innovation Development Center" aims to enhance the company's technological innovation capabilities and decision-making processes [3] Group 4 - Dezheng Health's strategic technological layout is seen as a significant milestone for the company's development, aiming to accelerate innovation and transformation in the pharmaceutical industry [4] - The collaboration with the academician workstation and expert resources will strengthen the company's internal innovation capabilities and support the advancement of its drug development pipeline [4] - This initiative is expected to inject strong momentum into the technological innovation development of Xinjiang's pharmaceutical sector [4]

Group 1 - The establishment of the academician expert workstation at Deyizhi Pharmaceutical Co., Ltd. is approved by the Beijing Association for Science and Technology, marking a significant step in the company's innovation-driven development strategy [1] - The collaboration with Academician Yang Baofeng will focus on drug research and development in various fields, including cardiovascular diseases, tumors, metabolic system diseases, pulmonary hypertension, and neurological disorders [1][2] - Deyizhi Health is actively advancing several innovative drug projects, including neuroprotective agents, antithrombotic drugs, and cannabinoid-related medications [2] Group 2 - The partnership with Academician Yang Baofeng's team is expected to enhance the company's technological capabilities and innovation strategies, leading to the development of competitive new products and processes [2] - The approval of the academician expert workstation is seen as a crucial move to improve the company's research capabilities, attract high-end talent, and promote the transformation of research results [3] - The company aims to strengthen existing innovation platforms, enhance technological innovation capabilities, and accelerate the industrialization of research achievements to drive revenue growth and diversify its business structure [3]